Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effectiveness of Nano-Curcumin on Patients With Covid-19: A Systematic Review of Clinical Trials Publisher Pubmed



Shojaei M1 ; Foshati S2 ; Abdi M1 ; Askari G3, 4 ; Sukhorukov VN5 ; Bagherniya M3, 4 ; Sahebkar A6, 7, 8, 9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Food Security Research Center, Department of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Anesthesia and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Institute for Atherosclerosis Research, Moscow, Russian Federation
  6. 6. Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  7. 7. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
  8. 8. School of Medicine, The University of Western Australia, Perth, Australia
  9. 9. Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Source: Phytotherapy Research Published:2023


Abstract

The main aim of the current study was to summarize the findings of available clinical studies to assess nano-curcumin's influence on COVID patients. A comprehensive online search was performed in Scopus, PubMed, ISI Web of Science, and Google Scholar until March 2022 to identify trials that investigated the effects of nano-curcumin in patients with COVID-19. Eight studies comprising 569 patients were included in this review. Compared with placebo, nano-curcumin had no significant effect on C-reactive protein (CRP) and high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6). However, gene expression of IL-6 and gene expression as well as secretion of interleukin-1 beta (IL-1β) significantly decreased following nano-curcumin intervention. Nano-curcumin had beneficial effects on fever, cough, chills, myalgia, and olfactory and taste disturbances. The duration of hospitalization and mortality rate were significantly lower in the nano-curcumin group compared with the control group. Lymphocyte count was significantly increased after curcumin supplementation. Nano-curcumin also had favorable effects on O2 saturation, sputum, chest pain, wheeze, and dyspnea in patients with COVID-19. No major adverse effects were reported in response to nano-curcumin supplementation. In summary, the results of this systematic review of clinical trials suggested that nano-curcumin supplementation has beneficial effects on inflammation, respiratory function, disease manifestations, and complications in patients with COVID-19 viral infection. © 2023 John Wiley & Sons Ltd.
Other Related Docs
20. Turmeric (Curcuma Longa L.) Usage in the Middle East a Comprehensive Review, Ancient and Traditional Foods, Plants, Herbs and Spices used in the Middle East (2023)
24. Curcumin and Piperine in Covid-19: A Promising Duo to the Rescue?, Advances in Experimental Medicine and Biology (2021)
49. Saffron (Crocus Sativus) As a Middle East Herb: Traditional and Modern Medicinal Applications, Ancient and Traditional Foods, Plants, Herbs and Spices used in the Middle East (2023)